Here's why this is a big deal.
While many practitioners typically use a traditional needle to inject this type of cheek filler, a cannula also works well to inject the mid-face area. According to Carrie Strom, senior vice president of U.S. medical aesthetics at Allergan, the company that manufactures Juvéderm , it’s a method that many doctors were already using for this purpose.
In other words, with many doctors already preferring cannulas to inject Juvéderm Voluma XC into the cheek area, it made sense for Allergan to invest in a clinical study to back up the claims, and also educate other doctors about the potential benefits of the cannula versus a needle.
Additionally, "Cannulas tend to be longer than most needles and therefore reach more areas with fewer entry points into the skin," explains New York City dermatologist Ellen Marmur. Fewer entry points to the skin , mean that for Marmur, she "can treat the entire cheekbone, undereye, and midface with one injection with a cannula.
The bottom line, though, according to Zeichner, is that every doctor is different and should be able to inject using the method that they personally prefer. Basically, this approval just provides them with another tool in their injectables toolbox. Zeichner aptly likens it to an artist, who "can use many different types of brushes to create beautiful work on the canvas."
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Juul says it will keep running 'Make the Switch' ad campaign despite FDA concernsThe FDA sent Juul a warning letter this week about its campaign urging people to 'Make the Switch' from cigarettes, but the company isn't backing down.
Consulte Mais informação »
Column: A stem cell clinic under fire by the FDA and ex-patients files for bankruptcyA La Jolla clinic pitching $15,000 stem cell treatments files for bankruptcy, facing a lawsuit from former patients.
Consulte Mais informação »
FDA finds impurity in popular heartburn medicine Zantac that could cause cancerThe FDA has learned that Sanofi's heartburn medication Zantac carries a substance that could cause cancer.
Consulte Mais informação »
GE Healthcare earned FDA clearance for its AI-powered portable x-rayGE Healthcare earned the FDA's approval for its AI-powered mobile X-ray device – marking the first time the FDA has cleared a tool of its kind.
Consulte Mais informação »
FDA advisory committee to vote on peanut allergy treatmentAn advisory committee for the FDA will vote today on whether to recommend a peanut allergy treatment for FDA approval.
Consulte Mais informação »